Manuel Rubio‐Rivas

The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements

Anna‐Maria Hoffmann‐Vold, Toby M. Maher, E. Philpot et al. · The Lancet Rheumatology · 2020 · 300 citations

Medicine, Clinical Sciences, Internal Medicine +16

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry

José Manuel Casas Rojo, Juan Miguel Antón Santos, Jesús Millán-Núñez-Cortés et al. · Revista Clínica Española (English Edition) · 2020 · 269 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +11

Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis

Juan Mañá, Manuel Rubio‐Rivas, N Martínez Villalba et al. · Medicine · 2017 · 141 citations · Full text

Medicine, Clinical Sciences, Pathology +6

Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID

Jorge Calderón‐Parra, Antonio Muiño-Míguez, Alejandro David Bendala Estrada et al. · PLoS ONE · 2021 · 120 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +11

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Luis M. Pérez-Belmonte, José D. Torres‐Peña, María D. López-Carmona et al. · BMC Medicine · 2020 · 103 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17